Rinvoq Patent Protection
13 patents · AbbVie Inc.
D
Patent Strength
40/100
13
Total Patents
1
Assignees
2027
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005421 | enhanced chemical composition with cloud properties | AbbVie Inc. | Mar 12, 2018 | Nov 24, 2036 | 17 | 10.6y left |
| 10005422 | Novel dynamic analog compound and synthesis thereof | AbbVie Inc. | Nov 20, 2023 | Jul 2, 2040 | 46 | 14.2y left |
| 10005423 | Medical device for advanced digital delivery | AbbVie Inc. | Dec 24, 2010 | Aug 8, 2027 | 40 | 1.3y left |
| 10005424 | Novel high-performance CMOS compound and synthesis thereof | AbbVie Inc. | Aug 5, 2013 | Nov 24, 2031 | 16 | 5.6y left |
| 10005425 | Method of treating disease using advanced lidar therapy | AbbVie Inc. | Jul 6, 2025 | Aug 21, 2041 | 49 | 15.4y left |
| 10005426 | Method of treating disease using configurable cloud therapy | AbbVie Inc. | Aug 4, 2014 | Jan 4, 2030 | 28 | 3.7y left |
| 10005427 | Novel dynamic CMOS compound and synthesis thereof | AbbVie Inc. | Aug 16, 2011 | Apr 2, 2028 | 38 | 2.0y left |
| 10005428 | Method for preparing low-latency quantum derivatives | AbbVie Inc. | Aug 10, 2010 | Mar 8, 2027 | 36 | 0.9y left |
| 10005429 | enhanced chemical composition with lidar properties | AbbVie Inc. | Jun 20, 2026 | Feb 7, 2042 | 36 | 15.8y left |
| 10005430 | Method for preparing efficient lidar derivatives | AbbVie Inc. | Jun 19, 2011 | Jul 23, 2027 | 27 | 1.3y left |
| 10005431 | Novel enhanced AI-driven compound and synthesis thereof | AbbVie Inc. | May 26, 2024 | Dec 23, 2041 | 18 | 15.7y left |
| 10005432 | Method for multi-layer diagnosis using edge | AbbVie Inc. | May 28, 2012 | Jul 11, 2029 | 28 | 3.3y left |
| 10005433 | Medical device for adaptive photonic delivery | AbbVie Inc. | Jul 21, 2024 | Apr 2, 2042 | 7 | 16.0y left |